ArticleAnnals of hematology2026

Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial.

Yasmin H Karimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.